Worldwide Clinical Trials
Anna Kolos has a diverse work experience in the medical field. Anna currently works as a Medical Director at Worldwide Clinical Trials since April 2022. Prior to that, they held various positions at Premier Research, including Medical Director from January 2019 to March 2022, Medical Monitor from May 2018 to December 2018, Clinical Scientist from November 2017 to May 2018, and Clinical Research Associate from August 2016 to November 2017. Before joining Premier Research, Anna worked as a CRA at Quintiles from December 2015 to August 2016. Their earlier experience includes working as a Doctor (General Practice) at State Hospital No6 from August 2014 to August 2016.
Anna Kolos completed their Doctor of Medicine (MD) degree at Shupyk National Medical Academy of Postgraduate Education (NMAPE) from 2014 to 2016. Prior to that, they studied at Bogomolets National Medical University from 2008 to 2014 to obtain their first Doctor of Medicine (MD) degree.
This person is not in any teams
This person is not in any offices
Worldwide Clinical Trials
10 followers
About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.